Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Paul Laviolette
AddedMar 31, 2024
UpdatedMay 31, 2026
Paul Laviolette

Paul Laviolette

Board Member, Cibiem

CrunchbaseLinkedIn

Paul Laviolette's Career

Cibiem
Cibiem

Los Altos, CA, US

Board Member· Board
Valentx
Valentx

Maple Grove, MN, US

Board Member· Board
Cardiokinetix
Cardiokinetix

Menlo Park, CA, US

Board Member· Board
CSA Medical
CSA Medical

Lexington, KY, US

Board Member· Board
Endotronix
Endotronix

Lisle, IL, US

Board Member· Board
CardioFocus
CardioFocus

Marlborough, MA, US

Board Member· Board
Direct Flow Medical
Direct Flow Medical

Santa Rosa, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Paul Laviolette's Career

Cibiem
Cibiem
Acquired$13M02010Los Altos, CA, US
Board Member· Board

Leadership at Cibiem

Neil ExterNeil ExterBoard Member
Howard LevinHoward LevinCo-Founder
Mark GelfandMark GelfandCo-Founder
Hank KuchemanHank KuchemanBoard Member
Ken MartinKen MartinCEO

Similar to Cibiem

SeaStar MedicalSeaStar MedicalAnn Arbor, MI, USMedical Devicesest. 2007SeaStar MedicalAnn Arbor, MI, US · est. 2007

CytoPherx Inc. offers proprietary medical devices for treating inflammation-based diseases.

Series C · $50.2M5
ClarimedixClarimedixBoulder, CO, USMedical Devicesest. 2006ClarimedixBoulder, CO, US · est. 2006

Clarimedix, Inc., a US-based medical device company, specializes in treating vascular dysfunction.

Angel · $275k5
Valentx
Valentx
Seed$49.2M122002Maple Grove, MN, US
Board Member· Board

Leadership at Valentx

Mary Lincoln CampbellMary Lincoln CampbellBoard Member
Hans NeiszHans NeiszBoard Member
Bobby I Griffin \"Bob\"Bobby I Griffin \"Bob\"Board Member
Mitchell DannMitchell DannBoard Member
Cardiokinetix
Cardiokinetix
Acquired$112.5M02003Menlo Park, CA, US
Board Member· Board

Leadership at Cardiokinetix

Maria SainzMaria SainzBoard Member
Eric FainEric FainBoard Member
Rod FergusonRod FergusonBoard Member
Jeani DelagardelleJeani DelagardelleBoard Member
Frank GentileFrank GentileBoard Member
Casey TanseyCasey TanseyBoard Member
CSA Medical
CSA Medical

Lexington, KY, US

Board Member· Board
Endotronix
Endotronix

Lisle, IL, US

Board Member· Board
CardioFocus
CardioFocus

Marlborough, MA, US

Board Member· Board
Direct Flow Medical
Direct Flow Medical

Santa Rosa, CA, US

Board Member· Board

Paul Laviolette's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · KakaoSong Ji-Ho 'DeanSong Ji-Ho 'DeanBoard Member · Kakao

People Similar to Paul Laviolette

James GarveyJames GarveyCEO · SV Health InvestorsMarc-Andre MarcotteMarc-Andre MarcotteBoard Member · CurvaFixPatricia MarylandPatricia MarylandBoard Member · Encompass HealthCraig RosenCraig RosenBoard Member · VezaScott SerotaScott SerotaBoard Member · Henry ScheinBill LittleBill LittleBoard Member · Spectrawave